Graft-versus-host disease therapy: Something else beyond glucocorticoids?

Haematologica

Volumn 96, Issue 9, 2011, Pages 1249-1251

  Martínez, Carmen ^a   Urbano Ispízua, Álvaro ^b  

^a Dept Haematology   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; DENILEUKIN DIFTITOX; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 8; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RITUXIMAB; SCATTER FACTOR; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE NECROSIS; CHRONIC GRAFT VERSUS HOST DISEASE; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE MARKER; DRUG MEGADOSE; EDITORIAL; GRAFT VERSUS HOST REACTION; HUMAN; MEDICAL DECISION MAKING; MYOPATHY; OPPORTUNISTIC INFECTION; PNEUMONIA; RECURRENCE RISK; REGULATORY T LYMPHOCYTE;

FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SIROLIMUS;

EID: 80052358259     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.050534     Document Type: Editorial

References (23)

1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091-101
2. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, et al. A retrospective analysis of therapy for acute graft-versus host disease: initial treatment. Blood. 1990;76(8):1464-72
3. Vogelsang GB. How I treat chronic graft-versus-host disease. Blood. 2001;97(5):1196-201
4. Pidala J, Tomblyn M, Nishihori T, Field T, Ayala E, Perkins J, et al. Sirolimus demonstrates activity in the primary therapy of acute graftversus- host disease without systemic glucocorticoids. Haematologica. 2011;96(9):1351-6
5. van Dorp S, Resemann H, te Boome L, Pietersma F, van Baarle D, Gmelig-Meyling F, et al. The immunological phenotype of rituximabsensitive chronic graft-versus-host disease: a phase II study. Haematologica. 2011;96(9):1380-4
6. Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, et al. The kaleidoscope of glucocorticoid effects on immune system. Autoimmun Rev. 2011;10(6):305-10
7. Socié G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114(20):4327-36
8. Tivol E, Komorowski R, Drobyski WR. Emergent autoimmunity in graft-versus-host disease. Blood. 2005;105(12):4885-91
9. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2005; 105(7):2973-8
10. Sarantopoulos S, Stevenson KE, Kim HT, Cutler CS, Bhuiya NS, Schowalter M, et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood. 2009;113(6):3865-74
11. Cragg L, Blazar BR, Defor T, Kolatker N, Miller W, Kersey J, et al. A randomized trial comparing prednisone with antithymocyte globulin/ prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. Biol Blood Marrow Transplant. 2000; 6(4A):441-7
12. Levine JE, Paczesny S, Mineishi S, Braun T, Choi SW, Hutchinson RJ, et al. Etanercept plus methylprednisolone as initial therapy for acutegraft-versus-host disease. Blood. 2008;111(4):2470-5
13. Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, et al. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood. 2009;114(3):511-7
14. Doney KC, Weiden PL, Storb R, Thomas ED. Treatment of graft-versus- host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol. 1981;11(1):1-8
15. Deeg HJ, Loughran TP Jr, Storb R, Kennedy MS, Sullivan KM, Doney K, et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation. 1985;40(2):162-6
16. Cutler C, Li S, Ho VT, Koreth J, Alyea E, Soiffer RJ, et al. Extended follow- up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. Blood. 2007;109(7):3108-14
17. Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K, et al. Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation. 2001;72(12): 1924-9
18. Couriel DR, Saliba R, Escalon MP, Hsu Y, Ghosh S, Ippoliti C, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol. 2005;130(3):409-17
19. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biol Bone Marrow Transplant. 2005;11(12):945-55
20. Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, et al. Consensus conference on clinical practice in chronic graft-versushost disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant. 2010;16(12):1611-28
21. Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, et al. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2011;17(1):1-17
22. Kharfan-Dabaja MA, Mhaskar AR, Djulbegovic B, Cutler C, Mohty M, Kumar A. Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol Blood Marrow Transplant. 2009;15(9):1005-13
23. Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, et al. A biomarker panel for acute graft-versus-host disease. Blood. 2009;113(2):273-8.